These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 27049594

  • 1. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    Nord J Psychiatry; 2016 Aug; 70(6):450-5. PubMed ID: 27049594
    [Abstract] [Full Text] [Related]

  • 2. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 3. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland.
    Ingimarsson O, MacCabe JH, Sigurdsson E.
    Nord J Psychiatry; 2018 Oct 12; 72(7):497-500. PubMed ID: 30348045
    [Abstract] [Full Text] [Related]

  • 4. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    Nord J Psychiatry; 2017 Oct 12; 71(7):496-502. PubMed ID: 28632422
    [Abstract] [Full Text] [Related]

  • 5. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Constantine RJ, Andel R, McPherson M, Tandon R.
    Psychiatry Res; 2018 May 12; 263():238-244. PubMed ID: 29195836
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
    Thompson JV, Clark JM, Legge SE, Kadra G, Downs J, Walters JT, Hamshere ML, Hayes RD, Taylor D, MacCabe JH.
    J Psychopharmacol; 2016 May 12; 30(5):436-43. PubMed ID: 26905920
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI, Carroll C, Lage MJ, Fairman K.
    Psychiatr Serv; 2015 Feb 01; 66(2):127-33. PubMed ID: 25321616
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
    Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D.
    Br J Psychiatry; 2012 Dec 01; 201(6):481-5. PubMed ID: 22955007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictors of clozapine discontinuation in patients with schizophrenia.
    Krivoy A, Malka L, Fischel T, Weizman A, Valevski A.
    Int Clin Psychopharmacol; 2011 Nov 01; 26(6):311-5. PubMed ID: 21849905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of clozapine on polypharmacy.
    Chong SA, Remington GJ, Bezchlibnyk-Butler KZ.
    Psychiatr Serv; 2000 Feb 01; 51(2):250-2. PubMed ID: 10655014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.